T. Kawana, Sexually transmitted diseases of alpha herpes virus in women. Nihon Rinsho Jpn, J. Clin. Med, vol.58, pp.883-889, 2000.

L. Corey, H. G. Adams, Z. A. Brown, and K. K. Holmes, Genital herpes simplex virus infections: Clinical manifestations, course, and complications, Ann. Intern. Med, vol.98, pp.958-972, 1983.

R. Gupta, T. Warren, and A. Wald, Genital herpes, Lancet, vol.370, pp.2127-2137, 2007.

M. Lehtinen, P. Koskela, E. Jellum, A. Bloigu, T. Anttila et al., Herpes simplex virus and risk of cervical cancer: A longitudinal, nested case-control study in the Nordic countries, Am. J. Epidemiol, vol.156, pp.687-692, 2002.

A. Wald and K. Link, Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A meta-analysis, J. Infect. Dis, vol.185, pp.45-52, 2002.

C. L. Celum, The interaction between herpes simplex virus and human immunodeficiency virus, Herpes J. IHMF, vol.11, pp.36-45, 2004.

K. Looker, A. Magaret, K. Turner, P. Vickerman, S. Gottlieb et al., Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012, PLoS ONE, vol.10, 2015.

C. Johnston, D. M. Koelle, and A. Wald, HSV-2: In pursuit of a vaccine, J. Clin. Investig, vol.121, pp.4600-4609, 2011.

P. J. White and G. P. Garnett, Use of antiviral treatment and prophylaxis is unlikely to have a major impact on the prevalence of herpes simplex virus type 2, Sex. Trans. Infect, vol.75, pp.49-54, 1999.

T. H. Bacon, M. J. Levin, J. J. Leary, R. T. Sarisky, and D. Sutton, Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy, Clin. Microbiol. Rev, vol.16, 2003.

G. L. Johnson, L. Limon, G. Trikha, and H. Wall, Acute renal failure and neurotoxicity following oral acyclovir, Ann. Pharm, vol.28, pp.460-463, 1994.

M. E. Ernst and R. J. Franey, Acyclovir-and ganciclovir-induced neurotoxicity, Ann. Pharm, vol.32, pp.111-113, 1998.

S. K. De, J. C. Hart, and J. Breuer, Herpes simplex virus and varicella zoster virus: Recent advances in therapy, Curr. Opin. Infect. Dis, vol.28, pp.589-595, 2015.

R. N. Khurana, A. Charonis, M. A. Samuel, A. Gupta, and K. A. Tawansy, Intravenous foscarnet in the management of acyclovir-resistant herpes simplex virus type 2 in acute retinal necrosis in children, Med. Sci. Monit, vol.11, pp.75-78, 2005.

Y. Wu, V. Pons, A. Goudet, L. Panigai, A. Fischer et al., ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01675662

K. Sandvig and B. Van-deurs, Delivery into cells: Lessons learned from plant and bacterial toxins, Gene Ther, vol.12, pp.865-872, 2005.

J. M. White and G. R. Whittaker, Fusion of Enveloped Viruses in Endosomes, Traffic, vol.17, pp.593-614, 2016.

L. Moal, V. Loiseau, and P. M. , Leishmania hijacking of the macrophage intracellular compartments, Febs J, vol.283, pp.598-607, 2016.

R. C. Brady and D. I. Bernstein, Treatment of herpes simplex virus infections, Antivir. Res, vol.61, pp.73-81, 2004.

A. Savarino, J. R. Boelaert, A. Cassone, G. Majori, and R. Cauda, Effects of chloroquine on viral infections: An old drug against today's diseases?, Lancet Infect. Dis, vol.3, pp.722-727, 2003.

N. Storey, D. Latchman, and S. Bevan, Selective internalization of sodium channels in rat dorsal root ganglion neurons infected with herpes simplex virus-1, J. Cell Biol, vol.158, pp.1251-1262, 2002.

C. A. Harley, A. Dasgupta, and D. W. Wilson, Characterization of herpes simplex virus-containing organelles by subcellular fractionation: Role for organelle acidification in assembly of infectious particles, J. Virol, vol.75, pp.1236-1251, 2001.

L. Mcclain, Y. Zhi, H. Cheng, A. Ghosh, P. Piazza et al., Broad-spectrum non-nucleoside inhibitors of human herpesviruses, Antivir. Res, vol.121, pp.16-23, 2015.

J. Lund, A. Sato, S. Akira, R. Medzhitov, and A. Iwasaki, Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells, J. Exp. Med, vol.198, pp.513-520, 2003.

S. P. Crouch, R. Kozlowski, K. J. Slater, and J. Fletcher, The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity, J. Immunol. Methods, vol.160, pp.81-88, 1993.

O. S. Weislow, R. Kiser, D. L. Fine, J. Bader, R. H. Shoemaker et al., New soluble-formazan assay for HIV-1 cytopathic effects: Application to high-flux screening of synthetic and natural products for AIDS-antiviral activity, J. Natl. Cancer Inst, vol.81, pp.577-586, 1989.

J. C. Brown and W. W. Newcomb, Herpesvirus capsid assembly: Insights from structural analysis, Curr. Opin. Virol, vol.1, pp.142-149, 2011.

F. Yao and E. Eriksson, Inhibition of herpes simplex virus type 2 (HSV-2) viral replication by the dominant negative mutant polypeptide of HSV-1 origin binding protein, Antivir. Res, vol.53, pp.127-133, 2002.

D. F. Argenta, I. T. Silva, V. L. Bassani, L. S. Koester, H. F. Teixeira et al., Antiherpes evaluation of soybean isoflavonoids, Arch. Virol, vol.160, pp.2335-2342, 2015.

M. B. Mues, N. Cheshenko, D. W. Wilson, L. Gunther-cummins, and B. C. Herold, Dynasore Disrupts Trafficking of Herpes Simplex Virus Proteins, J. Virol, vol.89, pp.6673-6684, 2015.

J. Reefschlager, P. Wutzler, K. D. Thiel, and G. Herrmann, Efficacy of 5-vinyl-1-beta-D-arabinofuranosyluracil (VaraU) against herpes simplex virus type 2 strains in cell cultures and against experimental herpes encephalitis in mice: Comparison with acyclovir and foscarnet, Pharm. Res, vol.4, pp.200-206, 1987.

A. Shestakov, H. Jenssen, I. Nordstrom, and K. Eriksson, Lactoferricin but not lactoferrin inhibit herpes simplex virus type 2 infection in mice, Antivir. Res, vol.93, pp.340-345, 2012.

L. Hong, X. Xu, L. Chen, B. Li, D. Wu et al., The anti-HSV-2 effect of alumen: In vitro and in vivo experimental studies, J. Huazhong Univ. Sci. Technol.-Med. Sci, vol.31, pp.828-833, 2011.

H. Cheng, C. Yang, T. Lin, L. Lin, L. Chiang et al., Isolated from Phyllanthus urinaria Linnea, Inhibits Herpes Simplex Virus Type 2 Infection through Inactivation of Viral Particles. Evid.-Based Complement, Altern. Med, 2011.

S. Hadigal and D. Shukla, Exploiting Herpes Simplex Virus Entry for Novel Therapeutics, vol.5, pp.1447-1465, 2013.

A. H. Koyama and T. Uchida, Quantitative studies on the maturation process of herpes simplex virus type 1 in Vero cells, Virus Res, vol.10, pp.281-285, 1988.

M. B. Parr, L. Kepple, M. R. Mcdermott, M. D. Drew, J. J. Bozzola et al., A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2, Lab. Investig. J. Tech. Methods Pathol, vol.70, pp.369-380, 1994.

S. Yin, Y. Li, H. Xia, J. Zhao, Z. Zhang et al., An improved system for the evaluation of antiviral compounds against herpes simplex virus type 2, J. Virol. Methods, vol.189, pp.317-320, 2013.

A. G. Drannik, K. Nag, J. Sallenave, and K. L. Rosenthal, Antiviral Activity of Trappin-2 and Elafin In Vitro and In Vivo against Genital Herpes, J. Virol, vol.87, pp.7526-7538, 2013.

Y. Tsuchiya, M. Shimizu, Y. Hiyama, K. Itoh, Y. Hashimoto et al., Antiviral activity of natural occurring flavonoids in vitro, Chem. Pharm. Bull, vol.33, pp.3881-3886, 1985.

Y. H. Gong, B. Matthews, D. Cheung, T. Tam, I. Gadawski et al., Sacks, S. Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication, Antivir. Res, vol.55, pp.319-329, 2002.

E. A. Harden, R. Falshaw, S. M. Carnachan, E. R. Kern, and M. N. Prichard, Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virus, Antivir. Res, vol.83, pp.282-289, 2009.

A. M. Agelidis and D. Shukla, Cell entry mechanisms of HSV: What we have learned in recent years, Future Virol, vol.10, pp.1145-1154, 2015.

J. Akhtar and D. Shukla, Viral entry mechanisms: Cellular and viral mediators of herpes simplex virus entry, Febs J, vol.276, pp.7228-7236, 2009.

K. Dan, K. Miyashita, Y. Seto, H. Fujita, and T. Yamase, The memory effect of heteropolyoxotungstate (PM-19) pretreatment on infection by herpes simplex virus at the penetration stage, Pharmacol. Res, vol.46, pp.357-362, 2002.

N. N. Kalu, P. J. Desai, C. M. Shirley, W. Gibson, P. A. Dennis et al., Nelfinavir Inhibits Maturation and Export of Herpes Simplex Virus 1, J. Virol, vol.88, pp.5455-5461, 2014.

D. J. Owen, C. M. Crump, and S. C. Graham, Tegument Assembly and Secondary Envelopment of Alphaherpesviruses, Viruses, vol.7, pp.5084-5114, 2015.

R. M. Mingo, J. Han, W. W. Newcomb, and J. C. Brown, Replication of Herpes Simplex Virus: Egress of Progeny Virus at Specialized Cell Membrane Sites, J. Virol, vol.86, pp.7084-7097, 2012.

H. Granzow, B. G. Klupp, W. Fuchs, J. Veits, N. Osterrieder et al., Egress of alphaherpesviruses: Comparative ultrastructural study, J. Virol, vol.75, pp.3675-3684, 2001.

M. L. Toews and D. B. Bylund, Pharmacologic principles for combination therapy, Proc. Am. Thorac. Soc, vol.2, pp.282-289, 2005.

G. Andrei and R. Snoeck, Herpes simplex virus drug-resistance: New mutations and insights, Curr. Opin. Infect. Dis, vol.26, pp.551-560, 2013.

E. Bekerman and S. Einav, Combating emerging viral threats, Science, vol.348, pp.282-283, 2015.